This document discusses the state of characterization of the eukaryotic proteome. It notes that as of 2019, around 20% of proteins in fission yeast and humans are still classified as having unknown biological processes. While the number of known or inferred protein roles has increased since 1992, progress in characterizing unknowns has been slow. Many recently characterized proteins in fission yeast are involved in non-core functions like environmental response, aging, and damage accumulation. The document calls for more research on these unknown and less studied proteins that are "hidden in plain sight" within the eukaryotic proteome.
Slides from my talk describing CE-Symm and my research on internal symmetry. It was given for jLBR, the weekly seminar series for our department at PSI.
3DSIG 2014 Presentation: Systematic detection of internal symmetry in proteinsSpencer Bliven
These slides are from 3DSIG 2014, presented on July 11.
I describe our investigation of internal symmetry in protein structures. This is quite common (24% of domains), and has many implications for function, folding, and evolution.
I introduce the CE-Symm method, described in
Myers-Turnbull, D., Bliven, S. E., Rose, P. W., Aziz, Z. K., Youkharibache, P., Bourne, P. E., & Prlić, A. (2014). Systematic Detection of Internal Symmetry in Proteins Using CE-Symm. Journal of Molecular Biology, 426(11), 2255–2268. doi:10.1016/j.jmb.2014.03.010
I discuss the results from running CE-Symm across the PDB, as well as some particularly compelling examples.
See also my poster by the same title for more details.
Journal club presentation on:
Pandya, C., Brown, S., Pieper, U., Šali, A., Dunaway-Mariano, D., Babbitt, P. C., et al. (2013). Consequences of domain insertion on sequence-structure divergence in a superfold. Proceedings of the National Academy of Sciences of the United States of America, 110(36), E3381–7. doi:10.1073/pnas.1305519110
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Scott Schweikart, Senior Research Associate, Council on Ethical and Judicial Affairs, American Medical Association and Legal Editor, AMA Journal of Ethics - Human Gene Editing: An Ethical Analysis and Arguments for Regulatory Guidance at Both the National and Global Levels
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
Slides from my talk describing CE-Symm and my research on internal symmetry. It was given for jLBR, the weekly seminar series for our department at PSI.
3DSIG 2014 Presentation: Systematic detection of internal symmetry in proteinsSpencer Bliven
These slides are from 3DSIG 2014, presented on July 11.
I describe our investigation of internal symmetry in protein structures. This is quite common (24% of domains), and has many implications for function, folding, and evolution.
I introduce the CE-Symm method, described in
Myers-Turnbull, D., Bliven, S. E., Rose, P. W., Aziz, Z. K., Youkharibache, P., Bourne, P. E., & Prlić, A. (2014). Systematic Detection of Internal Symmetry in Proteins Using CE-Symm. Journal of Molecular Biology, 426(11), 2255–2268. doi:10.1016/j.jmb.2014.03.010
I discuss the results from running CE-Symm across the PDB, as well as some particularly compelling examples.
See also my poster by the same title for more details.
Journal club presentation on:
Pandya, C., Brown, S., Pieper, U., Šali, A., Dunaway-Mariano, D., Babbitt, P. C., et al. (2013). Consequences of domain insertion on sequence-structure divergence in a superfold. Proceedings of the National Academy of Sciences of the United States of America, 110(36), E3381–7. doi:10.1073/pnas.1305519110
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Scott Schweikart, Senior Research Associate, Council on Ethical and Judicial Affairs, American Medical Association and Legal Editor, AMA Journal of Ethics - Human Gene Editing: An Ethical Analysis and Arguments for Regulatory Guidance at Both the National and Global Levels
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
Keynote presentation, 4th February 2015, León, México - part of the 2015 Genomics Research on Plant-Parasite Interactions to Increase Food Production UK-MX Workshop.
A Systems Biology Approach to Natural Products ResearchHuda Nazeer
Explains the systems biology approach (holistic approach), its advantages and tools used compared to the reductionist approach in natural products research.
Lecture from whole-cell modeling summer school March 3-9, 2015 at the University of Rostock. See http://sites.google.com/site/vwwholecellsummerschool/ for more information.
The Nature and The Functional Complexity of Retrograde Signals. Retrograde signaling refers to the fact that chloroplasts and mitochondria utilize specific signaling molecules to convey information on their developmental and physiological states to the nucleus and modulate the expression of nuclear genes accordingly.
Personalized Medicine and the Omics Revolution by Professor Mike SnyderThe Hive
Personalized medicine is expected to benefit from the combination of genomic information with the global monitoring of molecular components and physiological states. To ascertain whether this can be achieved, we determined the whole genome sequence of an individual at high accuracy and performed an integrated Personal Omics Profiling (iPOP) analysis, combining genomic, transcriptomic, proteomic, metabolomic, and autoantibodyomic information, over a 38-month period that included healthy and two virally infected states. Our iPOP analysis of blood components revealed extensive, dynamic and broad changes in diverse molecular components and biological pathways across healthy and disease conditions. Importantly, genomic information was also used to estimate medical risks, including Type 2 Diabetes, whose onset was observed during the course of our study. Our study demonstrates that longitudinal personal omics profiling can relate genomic information to global functional omics activity for physiological and medical interpretation of healthy and disease states.
Meet the speaker, Professor Michael Snyder (Stanford):
Michael Snyder is the Stanford Ascherman Professor, Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. He received his Ph.D. from the California Institute of Technology and postdoctoral training at Stanford University. He is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has launched many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include; the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and within species. He has also combined different state-of–the-art omics technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. He is a co-founder of several biotechnology companies including; Protometrix (now part of Life Technologies), Affomix (now part of Illumina), Excelix, and Personalis, and he presently serves on the board of a number of companies.
The Microbiome of Research Animals : Implications for Reproducibility, Transl...QIAGEN
The human gut microbiota (GM) has emerged as a key factor in susceptibility to, as well as a potential biomarker of, several diseases and conditions. Similarly, researchers now appreciate that the GM of laboratory animals could affect the reproducibility and translatability of many disease models, including a complete loss of phenotype. While associations between characteristics of the GM and differential disease model phenotypes are of concern, they can also be viewed as sources of discovery related to disease pathogenesis. As such, there is considerable interest in factors that inadvertently influence the composition of the GM and methods of manipulating the GM prospectively to investigate such associations and standardize or optimize disease models. The webinar will present data on variables capable of influencing the GM of laboratory rodents citing several examples and animal models, considerations related to manipulation of the GM in mice and rats, and recent data supporting the use of “dirty” mice in biomedical research.
A guide to harnessing dna assembly for drug discoveryLinda Song
The slides covere key concepts in DNA assembly, discuss the importance of analyzing combinatorial libraries of genetic designs, and highlight emerging areas of research. These main points include an example application of DNA assembly for the production of a natural product with promising pre-clinical bioactivity. Learn more: http://ow.ly/UWqM30kD6GZ.
Curators are necessarily detail oriented -- a trait born of, and reinforced by, our efforts to describe biological data accurately and precisely. To ensure comprehensive coverage and meaningful integration of new and existing knowledge, however, it is important to periodically step back from this fine-grained view and assess emergent features in accumulated curation. I will explore how PomBase has used the global "big picture" view of curated data to provide biological summaries, modularise content, and improve data display and access for our users. The global perspective can also be used to detect annotation errors and identify knowledge gaps, thereby improving overall annotation quality. I will also describe the progress we have made in engaging fission yeast researchers in community curation. Finally, I will show that the global curation perspective and community engagement share a common theme: both improve overall understanding, accessibility and reuse of accumulated knowledge by our user community.
Keynote presentation, 4th February 2015, León, México - part of the 2015 Genomics Research on Plant-Parasite Interactions to Increase Food Production UK-MX Workshop.
A Systems Biology Approach to Natural Products ResearchHuda Nazeer
Explains the systems biology approach (holistic approach), its advantages and tools used compared to the reductionist approach in natural products research.
Lecture from whole-cell modeling summer school March 3-9, 2015 at the University of Rostock. See http://sites.google.com/site/vwwholecellsummerschool/ for more information.
The Nature and The Functional Complexity of Retrograde Signals. Retrograde signaling refers to the fact that chloroplasts and mitochondria utilize specific signaling molecules to convey information on their developmental and physiological states to the nucleus and modulate the expression of nuclear genes accordingly.
Personalized Medicine and the Omics Revolution by Professor Mike SnyderThe Hive
Personalized medicine is expected to benefit from the combination of genomic information with the global monitoring of molecular components and physiological states. To ascertain whether this can be achieved, we determined the whole genome sequence of an individual at high accuracy and performed an integrated Personal Omics Profiling (iPOP) analysis, combining genomic, transcriptomic, proteomic, metabolomic, and autoantibodyomic information, over a 38-month period that included healthy and two virally infected states. Our iPOP analysis of blood components revealed extensive, dynamic and broad changes in diverse molecular components and biological pathways across healthy and disease conditions. Importantly, genomic information was also used to estimate medical risks, including Type 2 Diabetes, whose onset was observed during the course of our study. Our study demonstrates that longitudinal personal omics profiling can relate genomic information to global functional omics activity for physiological and medical interpretation of healthy and disease states.
Meet the speaker, Professor Michael Snyder (Stanford):
Michael Snyder is the Stanford Ascherman Professor, Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. He received his Ph.D. from the California Institute of Technology and postdoctoral training at Stanford University. He is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has launched many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include; the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and within species. He has also combined different state-of–the-art omics technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. He is a co-founder of several biotechnology companies including; Protometrix (now part of Life Technologies), Affomix (now part of Illumina), Excelix, and Personalis, and he presently serves on the board of a number of companies.
The Microbiome of Research Animals : Implications for Reproducibility, Transl...QIAGEN
The human gut microbiota (GM) has emerged as a key factor in susceptibility to, as well as a potential biomarker of, several diseases and conditions. Similarly, researchers now appreciate that the GM of laboratory animals could affect the reproducibility and translatability of many disease models, including a complete loss of phenotype. While associations between characteristics of the GM and differential disease model phenotypes are of concern, they can also be viewed as sources of discovery related to disease pathogenesis. As such, there is considerable interest in factors that inadvertently influence the composition of the GM and methods of manipulating the GM prospectively to investigate such associations and standardize or optimize disease models. The webinar will present data on variables capable of influencing the GM of laboratory rodents citing several examples and animal models, considerations related to manipulation of the GM in mice and rats, and recent data supporting the use of “dirty” mice in biomedical research.
A guide to harnessing dna assembly for drug discoveryLinda Song
The slides covere key concepts in DNA assembly, discuss the importance of analyzing combinatorial libraries of genetic designs, and highlight emerging areas of research. These main points include an example application of DNA assembly for the production of a natural product with promising pre-clinical bioactivity. Learn more: http://ow.ly/UWqM30kD6GZ.
Curators are necessarily detail oriented -- a trait born of, and reinforced by, our efforts to describe biological data accurately and precisely. To ensure comprehensive coverage and meaningful integration of new and existing knowledge, however, it is important to periodically step back from this fine-grained view and assess emergent features in accumulated curation. I will explore how PomBase has used the global "big picture" view of curated data to provide biological summaries, modularise content, and improve data display and access for our users. The global perspective can also be used to detect annotation errors and identify knowledge gaps, thereby improving overall annotation quality. I will also describe the progress we have made in engaging fission yeast researchers in community curation. Finally, I will show that the global curation perspective and community engagement share a common theme: both improve overall understanding, accessibility and reuse of accumulated knowledge by our user community.
How bioinformatic and sequencing data might inform the regulatory process - O...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Is microbial ecology driven by roaming genes?beiko
Microbial ecology often makes assumptions about the relationship between phylogeny and function, but these assumptions can be invalidated by lateral gene transfer. We need to take a broader view of relationships between genes and genomes in order to make better sense out of microbes.
The flood of nextgen sequencing data is changing the landscape of computation biology, pushing the need for more robust infrastructures, tools, and visualization techniques.
Long-lasting alterations to DNA methylation and ncRNAs could underlie the eff...Ben Laufer
Fetal alcohol spectrum disorders (FASDs) are characterized by life-long changes in gene expression, neurodevelopment and behavior. What mechanisms initiate and maintain these changes are not known, but current research suggests a role for alcohol-induced epigenetic changes. We assessed alterations to adult mouse brain tissue by assaying DNA cytosine methylation and small noncoding RNA (ncRNA) expression, specifically the microRNA (miRNA) and small nucleolar RNA (snoRNA) subtypes. We found long-lasting alterations in DNA methylation as a result of fetal alcohol exposure, specifically in the imprinted regions of the genome harboring ncRNAs and sequences interacting with regulatory proteins. The findings of this study help to expand on the mechanisms behind the long-lasting changes in the brain transcriptome of FASD individuals.
Webinar Link: http://www.youtube.com/watch?v=fzdc0GIdCnA
Domains of unknown function are essential in yeastLaura Berry
Presented in the Synthetic Biology & Gene Editing strand of the 4Bio Summit. For more information, visit:
www.global-engage.com
~25% of yeast essential domains of unknown function (yeDUFs) are broadly conserved across all kingdoms of life (including Bacteria), while a small number are found in large numbers of proteins in mammals. In this presentation, Norman Goodacre from the FDA discusses 68 yeDUFs and their roles in alternative carbohydrate metabolism, mitochondrial transport, nuclear pore complex, mRNA processing, initiation of translation, protein complex assembly, and membrane-binding.
Bioinformatics: Building the cornerstones of Sequence Homology and its use fo...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
The Longevity Genie is an open-source toolbox and a chatbot that aims to enhance the capacity of large language models (LLMs) to address inquiries on personal health, genetics, and longevity research.
Applications of bioinformatics, main by kk sahuKAUSHAL SAHU
Introduction
Goals of Bioinformatics
Bioinformatics & Human Genome
Project
What can we do using bioinformatics ?
Applications of bioinformatics in various fields
1) Medicine
2) Evolutionary studies
3) Agriculture
4) Microbiology
5) Biotechnology
Conclusion
References
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Go users meeting, unknowns
1. What is left to discover in
the eukaryotic proteome?
GO users meeting, Berkeley, Oct 2019
Valerie Wood,
PomBase,
Department of Biochemistry,
University of Cambridge, UK
2. Only ~ 36% of predicted proteins were known
or inferred role
1992
6. Intersection
Metabolic process ∩
cellular process 3167
‘High level’ terms are often uninformative for
physiological role
Fission yeast: 4369 proteins with biological process annotation
metabolic process
3237
75% of BP
annotated
proteins
cellular process
4112
Other process terms excluded
response to (chemical)
phosphorylation
(can also apply to any module)
Terms which apply across annotation space are
often too general to be informative about
physiological role (for a biologist).
Slims with specificity are more useful.
7. Classifying ‘knowns’ using 53 Gene Ontology
biological process
Terms selected align with recognised ‘modules’ of biology
2018
11. Slow progress characterizing unknowns
20% pombe and cerevisiae
still “unknown process”
Hidden in plain sight: what remains to be discovered in the eukaryotic proteome? PMID:30938578
2019
12. 117 terms
53 terms
Extended GO terms to
cover multicellular process
annotation
Hidden in plain sight: what remains to be discovered in the eukaryotic proteome? PMID:30938578
2019
20% of human also
unknown (confirmed this)
What about human?
70% of human research is on
proteins known pre genome
sequence (Edwards et al 2011 PMID:21307913)
13. Why are unknowns unstudied?
27
Based on recent gene characterizations
in fission yeast
Most recently characterised proteins are
involved in non-core functions:
● environment responsive or aging
related processes: detoxification,
proteostasis, lipidostasis, damage
accumulation.
● Processes that are only required over
longer timescales
● Less than 25% are “housekeeping “
processes
Hidden in plain sight: what remains to be discovered in the eukaryotic proteome? PMID:30938578
2019
14. Hidden in plain sight: what remains to be discovered in the eukaryotic proteome? PMID:30938578
2019
15. Acknowledgements
The PomBase team
Kim Rutherford, Uni. of Cambridge (developer)
Midori Harris, Uni. of Cambridge (curator, ontology
developer)
Antonia Lock, UCL(curator)
PIs
Steve Oliver, Uni. of Cambridge (Outgoing)
Juan Mata, Uni. of Cambridge (Incoming)
Jurg Bahler, Uni. UCL